Article
A $7 billion startup wanted to build patient-friendly healthcare. Its bet on buzzy weight-loss drugs is testing that vision.
Rating:
0.0
Views:
48
Likes:
1
Library:
1
Ro's new weight-loss program could be its fastest-growing business ever. But response delays, drug shortages, and insurance snags are testing the bet.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value